Abbott banks on glucose monitors, new launches to ride out China, currency hit
By Christy Santhosh and Puyaan Singh (Reuters) - Abbott Laboratories (NYSE:ABT) on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new...